Redx Pharma Plc Shares now trading on JP Jenkins - Seite 2
Veronika Oswald, Commercial Director of JP Jenkins said: “Red’s move from AIM to the JP Jenkins venue represents a significant step forward in our journey towards accessibility and liquidity for their investors. This transition underscores our commitment to fostering a dynamic and thriving investment environment. We're thrilled to embark on this new chapter with Redx, confident in the opportunities it will unlock for both companies."
For further information, please contact:
JP Jenkins Limited |
Redx Pharma Plc |
Contact: Veronika Oswald (Director) |
Caitlin Pearson (Head of Communications) |
+44 (0)20 7469 0937 |
01625 469 918 |
Lesen Sie auch
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service
1893571 01-May-2024